Use of paracetamol during pregnancy unchanged in the EU
Submitted by Anonymous (not verified) on 20 January 2026 - 15:21
Use of paracetamol during pregnancy unchanged in the EU
Good Clinical Practice Inspectors Working Group
Submitted by Anonymous (not verified) on 20 January 2026 - 15:07
Good Clinical Practice Inspectors Working Group
Annual report of the Good Clinical Practice Inspectors Working Group 2024
Submitted by Anonymous (not verified) on 20 January 2026 - 15:04
Annual report of the Good Clinical Practice Inspectors Working Group 2024
Human medicines European public assessment report (EPAR): Aflunov, zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Date of authorisation: 28/11/2010, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 20 January 2026 - 14:15
Human medicines European public assessment report (EPAR): Aflunov, zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted), Date of authorisation: 28/11/2010, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 20 January 2026 - 14:12
Human medicines European public assessment report (EPAR): Daptomycin Hospira, daptomycin, Date of authorisation: 22/03/2017, Revision: 16, Status: Authorised
Data access to medicinal products for human use - Chapter 5
Submitted by Anonymous (not verified) on 20 January 2026 - 13:22
Data access to medicinal products for human use - Chapter 5
Human medicines European public assessment report (EPAR): Tocilizumab STADA (previously Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 20 January 2026 - 13:15
Human medicines European public assessment report (EPAR): Tocilizumab STADA (previously Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised
Standard operating procedure for procedure to be followed when the incident management plan for medicines for veterinary use is triggered
Submitted by Anonymous (not verified) on 20 January 2026 - 13:05
Standard operating procedure for procedure to be followed when the incident management plan for medicines for veterinary use is triggered
New product information wording: extracts from PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC
Submitted by Anonymous (not verified) on 20 January 2026 - 10:11
New product information wording: extracts from PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC
Fourth European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025, 13:00 (CET) to 8 December 2025, 15:00 (CET)
Submitted by Anonymous (not verified) on 20 January 2026 - 10:11
Fourth European Medicines Agency (EMA) and European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025, 13:00 (CET) to 8 December 2025, 15:00 (CET)